Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Deutsch

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Archives of Gynecology and Obstetrics|March 3, 2022
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancerChiara Fischer, Thomas M Deutsch, Manuel Feisst, et al.
Breast Cancer Research and Treatment|October 4, 2016
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Juliane Nees, et al.
Oncotarget|September 9, 2017
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistryStefan Stefanovic, Ralph Wirtz, Thomas M Deutsch, et al.
Journal of Proteome Research|March 17, 2023
Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1Kai Bartkowiak, Parinaz Mossahebi Mohammadi, Sebastian Gärtner, et al.
Journal of Medical Internet Research|February 8, 2022
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective TrialJoachim Graf, Nina Sickenberger, Katharina Brusniak, et al.
Scientific Reports|January 31, 2025
Discovery of a sushi domain-containing protein 2-positive phenotype in circulating tumor cells of metastatic breast cancer patientsKai Bartkowiak, Parinaz Mossahebi Mohammadi, Paula Nissen, et al.
Journal of Medical Systems|July 4, 2026
AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose systemJonas Freudenberg, Johannes Knitza, Niklas Gremke, et al.
Breast Cancer Research and Treatment|October 3, 2018
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancerSarah F Jauch, Sabine Riethdorf, Martin R Sprick, et al.
Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Archives of Gynecology and Obstetrics|March 3, 2022
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancerChiara Fischer, Thomas M Deutsch, Manuel Feisst, et al.
Breast Cancer Research and Treatment|October 4, 2016
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Juliane Nees, et al.
Oncotarget|September 9, 2017
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistryStefan Stefanovic, Ralph Wirtz, Thomas M Deutsch, et al.
Journal of Proteome Research|March 17, 2023
Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1Kai Bartkowiak, Parinaz Mossahebi Mohammadi, Sebastian Gärtner, et al.
Journal of Medical Internet Research|February 8, 2022
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective TrialJoachim Graf, Nina Sickenberger, Katharina Brusniak, et al.
Scientific Reports|January 31, 2025
Discovery of a sushi domain-containing protein 2-positive phenotype in circulating tumor cells of metastatic breast cancer patientsKai Bartkowiak, Parinaz Mossahebi Mohammadi, Paula Nissen, et al.
Journal of Medical Systems|July 4, 2026
AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose systemJonas Freudenberg, Johannes Knitza, Niklas Gremke, et al.
Breast Cancer Research and Treatment|October 3, 2018
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancerSarah F Jauch, Sabine Riethdorf, Martin R Sprick, et al.
Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
Pageof 4